New monthly shot could transform opioid addiction treatment in developing nations
Disease control
Not yet recruiting
This study will test whether a long-acting injection called buprenorphine is acceptable and effective for treating opioid dependence in low- and middle-income countries. About 760 adults who inject drugs will receive the monthly shot and be followed for 48 weeks. The goal is to s…
Sponsor: PATH • Aim: Disease control
Last updated May 17, 2026 10:37 UTC